Who’s Affected?

Zantac linked to cancer

Were you or a loved one diagnosed with stomach cancer or bladder cancer after taking Zantac?

The drug company Sandoz Inc., makers of Ranitidine Hydrochloride Capsules 150mg and 300 mg (Zantac), has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA),” which is a probable human carcinogen.

The U.S. Food and Drug Administration issued an advisory on Sept. 13, 2019, warning the public of a Zantac cancer risk due to chemical contamination of the heartburn medication.



The FDA explained that medicines containing ranitidine, including Zantac (ranitidine), contain trace amounts of n-nitrosodimethylamine (NDMA). Laboratory tests have demonstrated NDMA to be a potent carcinogen.

Several Zantac recalls have been issued since contamination was first discovered. The first recall was issued on Sept. 23, 2019 by generic drug maker Sandoz. Several generic Zantac makers have also issued recalls including those that supply Zantac for Walgreens, Walmart, Rite Aid, and CVS.

Sanofi, makers of brand name Zantac, also initiated a recall on Oct. 18, 2019.

FDA officials are saying that people may continue to take Zantac and other ranitidine medications, but those who are on a prescription version should consult with their physicians in order to find out if an alternative treatment is available.

If you or a loved one took Zantac and went on to develop stomach cancer or bladder cancer, you may qualify to join this Zantac cancer lawsuit investigation.



Fill out the form on this page for a free case evaluation by a Zantac cancer injury attorney.

What is Zantac?

Zantac, generic ranitidine, is a medication that treats stomach acid levels in conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome (excess acid caused by tumors). Research published in 2012 also indicates that it may be effective in treating hives (urticaria).

Zantac may be taken orally or injected either into muscle tissue or a vein. Zantac is part of a class of antacids known as histamine (H2) blockers, which prevents the action of the naturally-occuring compound involved in localized immune response (such as sneezing, itching and watery eyes) as well as the regulation of the digestive process.

According to ClinCalc.com, there are approximately 15 million prescriptions for ranitidine written annually, making it the 50th most commonly-prescribed drug in the United States.

What is NDMA?

N-nitrosodimethylamine (NDMA) is a probable carcinogen. It is an industrial waste product, yellowish in appearance with a faint, distinctive odor. Found in cured meats and tobacco smoke, it is a common environmental contaminant. This substance has also been used as a stabilizer in industrial lubricants as well as an ingredient in rocket and jet fuel.



In 2018, NDMA contamination was discovered in a number of blood pressure medications known as ARB blockers, such as Valsartan. The source of the contamination was eventually traced back to a factory in China, where changes in the manufacturing process led to a chemical reaction, resulting in the formation of NDMA.

It is not yet known how NDMA came to contaminate Zantac.

Drugmaker Novartis announced on Sept. 19 that it was stopping distribution of generic Zantac. However, it is not being pulled from drugstores, WebMD reported.

Does Zantac Cause Cancer?

The FDA has not called upon patients to stop taking Zantac if they have been prescribed the medication by a doctor. Nonetheless, the FDA is advising patients who take Zantac regularly to speak with their health care providers about alternative treatments.

The federal agency also recommends that those who are taking the over-the-counter version to consider using other drugs that have been approved for their conditions or make lifestyle changes that may relieve the symptoms of GERD and other gastrointestinal conditions.

In addition to the FDA, drug agencies in other countries around the world have also began recalling the popular heartburn drug.

NDMA behaves like a cancer-causing chemical “because it modifies your DNA,” Stanford University professor Dr. William Mitch told ABC News.

Mitch is part of a research team at Stanford that has shown that there is a link between people who take Zantac and high levels of NDMA. The current theory is that there are enzymes in humans that create NDMA as a reaction to Zantac.

The Italian Drug Agency announced on Sept. 20 that all versions of Zantac that contained the active ingredient that was made at Saraca Laboratories Ltd. in India were being recalled. The Italian government also banned other Zantac products while it conducts tests to see if other versions are also contaminated.

Have Zantac Cancer Lawsuits Been Filed?

The first Zantac lawsuit filed drugmaker Sanofi was filed in California on the same day the FDA published its safety warning. A second lawsuit has been filed in Florida by a man who contracted breast cancer, a very rare form of the disease in men, after taking Zantac over a nine-year period.

Plaintiffs say that the drugmaker had an obligation to know about the potential for contamination and to advise the medical community of the danger.

There has been a large body of research published over the past decade, in which researchers have found that when ranitidine comes into contact with water, it can set off a chemical reaction that can result in the formation of NDMA. Although this research has been widely available, the defendants did not issue any warnings to consumers or their doctors, the lawsuits allege.

Should I File a Zantac Cancer Lawsuit?

If you or a loved one was diagnosed with stomach cancer or bladder cancer after taking Zantac or another ranitidine medication, you may qualify to join this Zantac cancer lawsuit investigation.

Learn more by filling out out the form on this page for a free case evaluation by a Zantac cancer injury lawyer.

Get Help – It’s Free

Join a Free Zantac Cancer Lawsuit Investigation

If you qualify, an attorney will contact you to discuss the details of your potential case at no charge to you.

PLEASE NOTE: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client or getting you dropped as a client.

E-mail any problems with this form to:
Questions@TopClassActions.com.

  • We tell you about cash you can claim every week! Subscribe to our free newsletter today.

After you fill out the form, the attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or class action lawsuit is best for you.

ATTORNEY ADVERTISING

The choice of a lawyer is an important decision and should not be based solely on advertisements.

Counsel responsible for this advertisement includes Robert Blanchard at:

Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A.

PAID ATTORNEY ADVERTISEMENT: THIS WEB PAGE IS AN ADVERTISEMENT AND THE PARTICIPATING ATTORNEY(S) ARE INCLUDED BECAUSE THEY PAY AN ADVERTISING FEE. Top Class Actions is not a law firm, lawyer referral service, or prepaid legal services plan. We do not endorse or recommend any third-party claims processing company, lawyer, or law firm who participates in the network. We do not make any representation, and have not made any judgment, as to the qualifications, expertise, or credentials of any participating lawyer or processing group. No representation is made that the quality of the legal services or claims processing to be performed is greater than the quality of legal services or claims processing performed by other lawyers or claims processing group. The information contained herein is not legal advice. Any information you submit to Top Class Actions does not create an attorney-client relationship and might not be protected by attorney-client privilege. Instead, your information will be forwarded to an attorney or claims processing firm for the purpose of a confidential review and potential representation. You should not use this website to submit confidential, time-sensitive, or privileged information. All photos contained on this website are of models and do not depict clients.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.

ATTORNEY ADVERTISING